Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference
At AmerisourceBergen, we're dedicated to fostering innovation and are driven by our commitment to improving patient health outcomes. As industry leaders, we take pride in our sponsorship of Asembia's 2023 Specialty Pharmacy Summit, where we shared our expertise and insights on topics critical to the future of healthcare. Our presentations and contributions covered a range of issues, from the rapidly evolving landscape of cell and gene therapy to the critical importance of being fully prepared for the Inflation Reduction Act, as well as the payer perspective on biosimilars. We aimed to promote strategic thinking and forward-looking solutions. Take a look at our contributions to this year's summit and stay updated on AmerisourceBergen news emerging from the event.
“AmerisourceBergen brings together different perspectives and ideas, which can lead to new solutions that we never even considered before. They are like a beacon of hope in an ever-changing world, shedding light on innovative paths forward that we might not have seen otherwise.”
~Director, Market Access, Large biopharma
Evolving the Healthcare Ecosystem to Support Cell & Gene Therapies for Patients
Analyzing the Inflation Reduction Act: What's Next for Biopharma
Are you ready for the Inflation Reduction Act?
Will Biosimilars be Larger than Life? A Review of Payer Response to Changes in the United States Biosimilars Landscape
Reducing barriers: New insights for improving patient access
Advanced strategies to reduce barriers to patient access
Biopharma companies face complex behind-the-scenes barriers that contribute to prescription abandonment by pharmacies, providers, and patients, limiting medication access for patients. New approaches to narrow network distribution, digital pharmacy, dynamic claims adjustment, and consignment allow biopharma companies to help better mitigate those barriers and enable patients to get and stay on therapy.
Various behind-the-scenes barriers in the prescription journey can prevent pharmacies from receiving clean, dispensable prescriptions, often leading to pharmacy abandonment. Digital pharmacies can help biopharma companies remove barriers, enabling dispensing pharmacies to receive clean, ready-to-dispense prescriptions. In addition to improving patient experience, digital pharmacies provide stakeholders with robust data to better understand barriers in the prescription journey and inform better decision-making for healthier outcomes.
More news and media coverage
TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
AJMC | The Center for Biosimilars
Asembia: Payers More Likely to Prefer Multiple Biosimilars for the Same Reference Product
Managed Healthcare Executive
The Future Has Arrived and Is Knocking. Getting Ready for the Arrival of Cell and Gene Therapy
Maximize payer engagement through digital channels
Missed our strategy session? Don't worry, it's not too late to learn how digital trends are transforming payer strategies in healthcare. Reach out to our team today and request a demonstration to discover the latest digital tools and insights for staying ahead in the ever-evolving healthcare landscape.